X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Emami Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs EMAMI LTD - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES EMAMI LTD AMAR REMEDIES/
EMAMI LTD
 
P/E (TTM) x -0.5 23.8 - View Chart
P/BV x 0.1 3.6 1.7% View Chart
Dividend Yield % 0.0 2.6 -  

Financials

 AMAR REMEDIES   EMAMI LTD
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
EMAMI LTD
Mar-18
AMAR REMEDIES/
EMAMI LTD
5-Yr Chart
Click to enlarge
High Rs1641,428 11.5%   
Low Rs861,000 8.6%   
Sales per share (Unadj.) Rs261.6111.5 234.7%  
Earnings per share (Unadj.) Rs17.413.5 128.4%  
Cash flow per share (Unadj.) Rs22.327.2 81.8%  
Dividends per share (Unadj.) Rs08.43 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs100.788.7 113.5%  
Shares outstanding (eoy) m26.16226.97 11.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.510.9 4.4%   
Avg P/E ratio x7.289.6 8.0%  
P/CF ratio (eoy) x5.644.6 12.6%  
Price / Book Value ratio x1.213.7 9.1%  
Dividend payout %062.2 0.0%   
Avg Mkt Cap Rs m3,270275,542 1.2%   
No. of employees `000NA3.3 0.0%   
Total wages/salary Rs m1632,547 6.4%   
Avg. sales/employee Rs ThNM7,687.0-  
Avg. wages/employee Rs ThNM773.5-  
Avg. net profit/employee Rs ThNM934.1-  
INCOME DATA
Net Sales Rs m6,84425,305 27.0%  
Other income Rs m21195 10.8%   
Total revenues Rs m6,86525,500 26.9%   
Gross profit Rs m1,1317,194 15.7%  
Depreciation Rs m1283,109 4.1%   
Interest Rs m398343 116.0%   
Profit before tax Rs m6263,938 15.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121863 14.0%   
Profit after tax Rs m4553,075 14.8%  
Gross profit margin %16.528.4 58.1%  
Effective tax rate %19.321.9 88.2%   
Net profit margin %6.612.2 54.7%  
BALANCE SHEET DATA
Current assets Rs m4,9047,008 70.0%   
Current liabilities Rs m3,5817,139 50.2%   
Net working cap to sales %19.3-0.5 -3,711.5%  
Current ratio x1.41.0 139.5%  
Inventory Days Days12428 444.2%  
Debtors Days Days10022 445.4%  
Net fixed assets Rs m1,6898,231 20.5%   
Share capital Rs m262227 115.4%   
"Free" reserves Rs m2,35819,909 11.8%   
Net worth Rs m2,63520,136 13.1%   
Long term debt Rs m5070-   
Total assets Rs m6,86228,007 24.5%  
Interest coverage x2.612.5 20.6%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.00.9 110.4%   
Return on assets %12.412.2 101.9%  
Return on equity %17.315.3 113.1%  
Return on capital %31.021.3 145.8%  
Exports to sales %4.03.9 102.5%   
Imports to sales %00-   
Exports (fob) Rs m273985 27.7%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2731,063 25.7%   
Fx outflow Rs m2400 0.5%   
Net fx Rs m271663 40.9%   
CASH FLOW
From Operations Rs m-3135,878 -5.3%  
From Investments Rs m-489-2,791 17.5%  
From Financial Activity Rs m769-3,237 -23.7%  
Net Cashflow Rs m-33-122 26.6%  

Share Holding

Indian Promoters % 25.5 70.6 36.1%  
Foreign collaborators % 0.0 2.2 -  
Indian inst/Mut Fund % 9.2 1.3 707.7%  
FIIs % 0.0 16.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 9.2 709.8%  
Shareholders   13,061 25,076 52.1%  
Pledged promoter(s) holding % 99.7 19.5 511.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   KARUTURI GLOBAL  GILLETTE INDIA  GODREJ INDUSTRIES  GODREJ CONSUMER  RELAXO FOOTWEARS  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

US-China Trade Talks, Domestic Air Passenger Traffic, and Top Stocks in Focus Today(Pre-Open)

Indian share markets continued to witness volatility during closing hours yesterday and ended on a flat note. Gains were seen in the realty sector and consumer durables sector.

Related Views on News

EMAMI LTD Announces Quarterly Results (4QFY19); Net Profit Down 7.8% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, EMAMI LTD has posted a net profit of Rs 561 m (down 7.8% YoY). Sales on the other hand came in at Rs 6 bn (up 3.7% YoY). Read on for a complete analysis of EMAMI LTD's quarterly results.

EMAMI LTD Announces Quarterly Results (3QFY19); Net Profit Down 6.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, EMAMI LTD has posted a net profit of Rs 1 bn (down 6.0% YoY). Sales on the other hand came in at Rs 8 bn (up 7.2% YoY). Read on for a complete analysis of EMAMI LTD's quarterly results.

EMAMI LTD Announces Quarterly Results (2QFY19); Net Profit Down 16.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, EMAMI LTD has posted a net profit of Rs 827 m (down 16.1% YoY). Sales on the other hand came in at Rs 6 bn (down 0.0% YoY). Read on for a complete analysis of EMAMI LTD's quarterly results.

EMAMI LTD Announces Quarterly Results (1QFY19); Net Profit Up 2491.3% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, EMAMI LTD has posted a net profit of Rs 270 m (up 2491.3% YoY). Sales on the other hand came in at Rs 6 bn (up 13.5% YoY). Read on for a complete analysis of EMAMI LTD's quarterly results.

EMAMI LTD Announces Quarterly Results (4QFY18); Net Profit Down 27.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, EMAMI LTD has posted a net profit of Rs 609 m (down 27.0% YoY). Sales on the other hand came in at Rs 6 bn (up 6.8% YoY). Read on for a complete analysis of EMAMI LTD's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - K.S.OILS LTD COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS